Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul 13;12(7):e9167.
doi: 10.7759/cureus.9167.

Acute Limb Ischemia in COVID-19 Disease: A Mysterious Coagulopathy

Affiliations
Case Reports

Acute Limb Ischemia in COVID-19 Disease: A Mysterious Coagulopathy

Shamsuddin Anwar et al. Cureus. .

Abstract

Severe coronavirus disease 2019 (COVID-19) as a respiratory tract infection has been noted to be a causative agent for acute respiratory distress syndrome, shock, and multiple organ failure. It is also being suggested that COVID-19 results in serious systemic coagulopathies similar to disseminated intravascular coagulation. We describe a case of severe arterial thrombosis induced by COVID-19 infection along with its pathological implications.

Keywords: covid 19; hematology-oncology; limb ischemia; world pandemic.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Arterial ultrasound of the left lower extremity with waveforms
The arterial ultrasound of the left lower extremity did not show any occlusions. CFA, common femoral artery; SFA Prox, superficial femoral artery proximal; SFA Mid, superficial femoral artery mid; SFA Dis, superficial femoral artery distal; Pop, popliteal; PTA, posterior tibial artery; Peron, peroneal; ATA, anterior tibial artery
Figure 2
Figure 2. CT angiogram of the lower extremities
The arrowhead showing reduced blood flow with blockage in the arterial vessels of the left lower extremity.

References

    1. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Jackson SP, Darbousset R, Schoenwaelder SM. Blood. 2019;133:906–918. - PubMed
    1. Coagulation abnormalities and thrombosis in patients with COVID-19. Levi M, Thachil J, Iba T, Levy JH. Lancet Haematol. 2020;7:438–440. - PMC - PubMed
    1. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Wan Y, Shang J, Graham R, Baric RS, Li F. J Virol. 2020;94:0–20. - PMC - PubMed
    1. Zhou Y, Fu B, Zheng X, et al. Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+ CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus [PREPRINT]
    1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Zhou F, Yu T, Du R, et al. Lancet. 2020;395:1054–1062. - PMC - PubMed

Publication types

LinkOut - more resources